DOCUMENTO DE CONSENSODiabetes mellitus y riesgo cardiovascular. Recomendaciones del grupo de trabajo Diabetes Mellitus y Enfermedad Cardiovascular de la Sociedad Española de Diabetes 2009Diabetes mellitus and cardiovascular risk. Recommendations of the working group of Diabetes Mellitus and Cardiovascular Disease of the Spanish Diabetes Society 2009☆☆
Section snippets
1. Riesgo cardiovascular
Los sujetos con diabetes tienen un riesgo de desarrollar enfermedad cardiovascular 2–4 veces superior al observado en la población general de similar edad y sexo, riesgo que se mantiene después de ajustar para otros factores clásicos de riesgo cardiovascular. En este sentido, las complicaciones cardiovasculares atribuibles a la arteriosclerosis son responsables del 70–80% de todas las causas de muerte en los sujetos con diabetes y representan más del 75% del total de hospitalizaciones por
Conclusiones
Los sujetos con diabetes deben ser considerados como sujetos de alto riesgo cardiovascular y en consecuencia, tributarios de una intervención enérgica para la prevención de la enfermedad cardiovascular. Existen claras evidencias de que la corrección de todos los factores de riesgo cardiovascular comporta una importante reducción de la morbimortalidad cardiovascular.
Bibliografía (38)
Type 2 diabetes, dyslipidemia, and vascular risk: rationale and evidence for correcting the lipid imbalance
Am Heart J
(2005)- et al.
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
Lancet
(2002) - et al.
Reporting rate of rhabdomyolysis with fenofibrate+statin versus gemfibrozil+any statin
Am J Cardiol
(2005) - et al.
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
Lancet
(1998) - et al.
C-reactive protein as a predictor of total arteriosclerotic outcomes in type 2 diabetic nephropathy
Kidney Int
(2005) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report
Circulation
(2002)Standards of Medical Care in Diabetes-2009
Diabetes Care
(2009)- et al.
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel
J Intern Medicine
(2006) Efficacy of cholesterol-lowering therapy in 18686 people with diabetes in 14 randomised trials of statins: a meta-analysis
Lancet
(2008)- et al.
How cost-effective is the treatment of dyslipidemia in patients with diabetes but without cardiovascular disease?
Diabetes Care
(2001)
Cost-effectiveness of intensive atorvastatin therapy in secondary cardiovascular prevention in the United Kingdom, Spain, and Germany, based on the Treating to New Targets study
Eur J Health Econ
Type 2 diabetes mellitus: a cardiovascular perspective
Int J Clin Pract
Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study
Ann Intern Med
Lipoprotein glycation and its metabolic consequences
Curr Opin Lipidol
Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study
Arch Intern Med
WHO definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1: Definition, diagnosis and classification of diabetes
WHO Bull
Diagnosis and Management of the Metabolic Syndrome. An American Heart Association/National Heart, Lung, and Blood Institute. Scientific Statement
Cardiol Rev
Third National Health and Nutrition Examination Survey (NHANES III); National Cholesterol Education Program (NCEP). NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older
Diabetes
Cited by (2)
Incretin analogs and inhibitors of DPP-4: Which is their role in the primary prevention of cardiovascular diseases?
2013, Revista Colombiana de Cardiologia
- ☆
De acuerdo con los autores y los editores, este artículo se publica simultáneamente y de forma íntegra en la revista Endocrinología y nutrición: Endocrinol Nutr. doi:10-016/j.endonu.2010.03.001.